NIH starts study of Covid infection and multisystem inflammatory syndrome
NIH has started an observational study has launched to evaluate the short- and long-term health outcomes of SARS-CoV-2 infection in children
This includes multisystem inflammatory...
SK Biopharmaceuticals, LifeSci Venture Partners announce partnership for Open Innovation
Innovative pharma company SK Biopharmaceuticals, Co., Ltd., has inked a pact with global life science venture capital firm LifeSci Venture Partners to collaborate on...
ResMed announces expansion of AirView remote monitoring for ventilation in India
ResMed has announced expansion of AirView for Ventilation, its cloud-based remote monitoring and management platform for respiratory care patients, in India.
According to the leading...
Moderna to supply additional 2 mn doses of Covid-19 vaccine to United Kingdom
Moderna, Inc. has announced a supply agreement with the United Kingdom government for an additional 2 million doses of mRNA-1273,
Moderna is a biotechnology company...
Covid-19 investigational therapeutics to be analysed in big clinical trials
Covid-19 investigational therapeutics are to be evaluated in large clinical trials. Two controlled, randomized Phase 3 clinical trials have started evaluating investigational monoclonal antibodies...
Aspirin being tested as possible treatment for Covid-19
The humble Aspirin is all set to take on the mighty Covid-19. For, the commonly used medicine is being investigated in the world’s largest...
Lupus Research Awards 2023 announced
The Lupus Research Alliance (LRA) announced the recipients of the newest Lupus Innovation Award (LIA) grants.
Collectively, the seven projects led by research teams from the U.S. and Europe explore multiple...
Covid-19 home-test company Selfdiagnostics to apply for authorisation
Selfdiagnostics, an European based company, is planning to submit request for authorisation of its molecular diagnostic test for home and for point of care...
Soterix announces expanded clinical trials for Alzheimer’s disease
Soterix Medical Inc has announced expanded clinical trials of its proprietary neuromodulation technologies for Alzheimer's disease and Mild Cognitive Impairment.
The company is a leaing...
Hydroxychloroquine doesn’t benefit adults hospitalised with Covid-19: NIH trial
A clinical trial by National Institutes of Health, evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with Covid-19, has concluded...